In 2014, Sabater described a novel disease, with sleep disturbances, cognitive and autonomic dysfunction, gait ataxia, bulbar dysarthria and dysphagia, movement disorders, which was found to have causative antibodies to IgLON5. 1 Anti-IgLON 5 Antibody disease is an autoimmune disorder likely to cause neurodegeneration, 2 which also explains the unresponsiveness of disease symptoms to immunomodulation. Early diagnosis and treatment may however reduce morbidity and mortality, as some cases do show a good response to treatment. Due to its novelty and increasingly wide phenotypic variability, Anti-IgLON5 disease poses challenges in recognition and diagnosis. We report a case with unusual head drops, dystonia and sleep orthopnea due to IgLON5 Ab-disease, with marked clinical improvement after immunotherapy.